Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Indian J Dent Res ; 34(2): 226-228, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37787218

RESUMO

Rationale: Angiosarcoma is a malignant mesenchymal tumor arising from vascular endothelial cells. This is an aggressive malignancy associated with poor prognosis. Angiosarcoma in the head and neck is exceedingly rare, accounting for less than 4 % of tumors.[1]. Patient Concern: We report a unique case of angiosarcoma involving the tongue underlying the diagnostic conundrum and pointers towards an accurate diagnosis. Take-away lesson: Due to rarity of the disease, consensus on optimal treatment approach is lacking and multicenter prospective studies would be helpful to set clinical guidelines.


Assuntos
Hemangiossarcoma , Humanos , Células Endoteliais/patologia , Cabeça/patologia , Hemangiossarcoma/diagnóstico , Hemangiossarcoma/patologia , Estudos Prospectivos , Língua/patologia
2.
J Maxillofac Oral Surg ; 22(2): 381-387, 2023 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-37122804

RESUMO

Aim: MicroRNAs have been widely acknowledged as a diagnostic, prognostic, and/or therapeutic biomarker for the progression of OSCC, but the correlation of hsa-miR-101-5p and hsa-miR-155-3p is yet to be established with c-Fos in OSCC and OSMF. Methodology: An observational study enrolled 40 patients divided into 2 groups: Group I-21 OSMF patients without malignant transformation, Group II-19 patients with locally advanced, large-operable, or metastatic OSCC, after applying inclusion and exclusion criteria. Both miRNAs were extracted and analyzed from the tissue sample excised from the involved site. The linear regression analysis of the expression of hsa-miR-155-3p, hsa-miR-101-5p, and levels of c-fos in OSMF and OSCC patients and its correlation for habits, age, and gender were evaluated. Results: The expression of hsa-miR-101-5p was 0.81 times downregulated in OSCC tissue compared to OSMF, whereas hsa-miR-155-3p and c-fos were both upregulated 9.30 times and 1.75 times, respectively, in OSCC tissue. In Gutkha and tobacco chewers, the hsa-miR-155-3p expression could explain 12.3% (p = 0.031) for Gutkha chewers, whereas c-fos could explain 38.6% of the cases (p = 0.020) for tobacco chewers. The expression of hsa-miR-101-5p and hsa-miR-155-3p explained 43.7% and 59.5% of OSCC cases in alcoholics, respectively. Interestingly, in non-alcoholics, hsa-miR-155-3p and hsa-miR-101-5p were significant predictors of OSCC. Conclusion: Downregulation of tumor-suppressor hsa-miR-101-5p and upregulation of proto-onco hsa-miR-155-3p is responsible for intricate regulation of the progression of OSMF to OSCC via deregulated expression of c-Fos and tobacco chewing and advancing age is significant contributors for OSCC.

3.
J Maxillofac Oral Surg ; 21(3): 881-887, 2022 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-36274903

RESUMO

Mucosal melanoma is an exceedingly rare and aggressive neoplasm with high mortality rate. In contrast to the cutaneous melanomas, the risk factors and pathogenesis are poorly understood. It is predominantly localized in the region of the hard palate and maxillary alveolus. Surgery is the mainstay of treatment, but it may turn out to be challenging depending on the anatomic location, extent and size of the tumor and presence of metastasis. Presented here is a series of two cases of maxillary mucosal melanoma with varied presentation.

4.
Int J Appl Basic Med Res ; 9(1): 62-64, 2019.
Artigo em Inglês | MEDLINE | ID: mdl-30820423

RESUMO

Sertoli-Leydig cell tumor (SLCT) of the ovary is an extremely uncommon neoplasm accounting for <0.5% of all primary ovarian neoplasms. These tumors belong to the category of sex cord-stromal tumors. The tumor has variable clinical and histopathological presentations complicating the diagnosis and therefore the treatment. The presence of heterologous elements is seen in one-fifth of these already rare neoplasms. Herein, we report a case of a 28-year-old female presenting with irregular menses, features of virilization, and abdominal pain. Histopathological examination revealed marked focal anaplasia in this tumor of, otherwise, intermediate differentiation along with the presence of heterologous elements. Reporting of such elements is imperative for adequate treatment and deciding follow-up.

5.
J Gynecol Obstet Hum Reprod ; 47(10): 533-537, 2018 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-29783035

RESUMO

OBJECTIVE: The present study aimed to investigate the changes of endometrial progesterone and estrogen receptors in luteal phase biopsy specimens of infertile women and find a correlation, if any, between these and CD8+ receptors in the same. METHODS: The study was conducted on luteal phase endometrial biopsy specimens of 30 women of unexplained infertility and 15 age matched controls. Paraffin sections were first H & E stained. A standardized immunohistochemical protocol was then used to localize the estrogen, progesterone and CD8+ receptors in these samples that were expressed as percentage positivity. Unpaired T test was applied between the controls and cases both for epithelial and stromal cells. The data was also analyzed for correlation in cases for the positivity of CD8+ Cells with that of ER and PR. RESULTS: The positivity of estrogen receptors (ER) in stromal cells was significantly lower (p<0.001) in the infertile women when compared to controls and in both the epithelial and stromal cells for progesterone receptors (p<0.001). The results were non significant for CD8+ cells (p=0.19) and also showed no significant correlation in the positivity of CD8+ cells with that of ER and PR. CONCLUSIONS: The development of molecular probe like ER and PR positivity in endometrial epithelial and stromal cells allows a new approach to be made to the characterization of normal and defective endometrial function.


Assuntos
Substância Própria/metabolismo , Endométrio/metabolismo , Epitélio/metabolismo , Infertilidade Feminina/metabolismo , Receptores de Antígenos de Linfócitos T/metabolismo , Receptores de Estrogênio/metabolismo , Receptores de Progesterona/metabolismo , Adulto , Biópsia , Feminino , Humanos , Imuno-Histoquímica , Fase Luteal , Adulto Jovem
7.
Diagn Cytopathol ; 44(6): 548-51, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27079183

RESUMO

Extraosseous giant cell tumors have been described in organs like larynx, thyroid, pancreas, heart, skin, lung, colon, kidney, and soft tissues (Wu et al., Oncol Lett 2013;6:829-832). Osteoclast-like giant cell tumor of the parotid gland has been reported only rarely with the first description of primary giant cell tumour of the parotid gland (GCTPs) given in 1984 by Eusebi et al. (Am J Clin Pathol. 1984;81:666-675). However, FNAC of osteoclast-like giant cell tumor of the parotid gland has not been well described, and only one case has been reported till date (Torabinezad et al., Acta Cytol. 2006;50:80-83). Two presentations have been observed in the form of either an isolated giant cell tumor (Eusebi et al., Am J Clin Pathol. 1984;81:666-675) or tumor associated with a carcinomatous component (Yang et al., Korean J Pathol 2012;46:297-301; Pasricha et al., J Can Res Ther 2013;9:314-316). GCTPs are uncommon benign soft tissue tumors with a malignant potential. Diagn. Cytopathol. 2016;44:548-551. © 2016 Wiley Periodicals, Inc.


Assuntos
Tumores de Células Gigantes/patologia , Osteoclastos/patologia , Neoplasias Parotídeas/patologia , Adulto , Biomarcadores Tumorais/metabolismo , Feminino , Tumores de Células Gigantes/diagnóstico por imagem , Tumores de Células Gigantes/metabolismo , Humanos , Neoplasias Parotídeas/diagnóstico por imagem , Neoplasias Parotídeas/metabolismo
8.
Postgrad Med J ; 89(1050): 185-92, 2013 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-23243150

RESUMO

OBJECTIVE: To analyse the clinicopathological presentation, outcome and importance of bone marrow haemophagocytosis in patients with infection-associated haemophagocytic lymphohistiocytosis (IA-HLH) in a tertiary care hospital in Northern India. STUDY DESIGN: Between January 2007 and December 2009, 26 consecutive patients meeting the diagnostic criteria for IA-HLH, based on the HLH2004 protocol of the Histiocyte Society, were followed up for between 12 and 34 months (median 20 months). RESULTS: IA-HLH was diagnosed in three of the five patients who died 5-6 weeks after the onset of the illness, whereas diagnosis in the remaining group was made a median of 2 weeks after the onset of the illness. The predominant presenting features were fever (100%), hepatomegaly (69%), splenomegaly (58%) and anaemia (96%). All patients showed >3% haemophagocytosis on bone marrow studies-in four cases after serial aspiration/biopsies. Twenty-one (80.8%) cases were non-fatal and five (19.2%) patients died. The non-fatal cases included eight (38.1%) cases of viral infection, seven (33.3%) bacterial infections, two (9.6%) fungal and four (19.0%) protozoal infections; whereas four (80%) bacterial infections and one (20%) viral infection were associated with the fatal cases. The mean of the nadir blood counts of white blood cells, absolute neutrophil counts and platelets; the mean of all the peak biochemical parameters of liver function tests, lactate dehydrogenase and ferritin and the lowest fibrinogen values before treatment, differed significantly (p<0.05) between the non-fatal and the fatal group, being worse in the latter. CONCLUSIONS: IA-HLH is important because it can obscure the typical clinical features of the underlying primary disease, thus delaying the diagnosis and having a negative effect on the outcome. Although bone marrow haemophagocytosis is not a mandatory diagnostic criterion, we found it to be a useful tool together with biochemical parameters for early recognition of HLH, especially in developing countries lacking molecular and flow laboratories. The severity of pancytopenia and derangement in biochemical markers were significantly higher in the patients who died.


Assuntos
Medula Óssea/imunologia , Infecções por Vírus Epstein-Barr/complicações , Infecções por Vírus Epstein-Barr/diagnóstico , Imunomodulação , Linfo-Histiocitose Hemofagocítica/diagnóstico , Fagocitose/imunologia , Adolescente , Adulto , Idoso , Biomarcadores/sangue , Criança , Análise Custo-Benefício , Diagnóstico Tardio , Países em Desenvolvimento , Progressão da Doença , Infecções por Vírus Epstein-Barr/sangue , Infecções por Vírus Epstein-Barr/mortalidade , Feminino , Ferritinas/sangue , Febre/virologia , Hepatomegalia/virologia , Humanos , Índia/epidemiologia , L-Lactato Desidrogenase/sangue , Testes de Função Hepática , Linfo-Histiocitose Hemofagocítica/sangue , Linfo-Histiocitose Hemofagocítica/mortalidade , Linfo-Histiocitose Hemofagocítica/virologia , Masculino , Pessoa de Meia-Idade , Contagem de Plaquetas , Fatores de Risco , Esplenomegalia/virologia , Viroses/complicações , Viroses/diagnóstico
9.
Cardiovasc Pathol ; 20(6): 384-5, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21109467

RESUMO

An unusual autopsy finding was seen in a young case of metastatic teratocarcinoma of the right testis. The patient presented with features of myocardial ischemia and died of sudden cardiac arrest. At autopsy, the lungs were studded with variably sized metastatic nodules composed of glistening hyaline cartilage. Examination of the coronary arteries revealed complete occlusion of the left anterior descending and left circumflex artery lumina by tumor emboli composed of glistening white chondromyxoid material. Histopathology confirmed the presence of mature hyaline cartilage and chondromyxoid material in tumor emboli. The individual died due to severe coronary insufficiency and sudden cardiac arrest secondary to complete luminal occlusion of the left anterior descending and left circumflex artery lumina by tumor emboli composed of hyaline cartilage.


Assuntos
Oclusão Coronária/etiologia , Morte Súbita Cardíaca/etiologia , Neoplasias Cardíacas/secundário , Neoplasias Pulmonares/secundário , Teratocarcinoma/secundário , Neoplasias Testiculares/patologia , Adulto , Autopsia , Oclusão Coronária/patologia , Morte Súbita Cardíaca/patologia , Evolução Fatal , Neoplasias Cardíacas/complicações , Humanos , Cartilagem Hialina/patologia , Neoplasias Pulmonares/complicações , Masculino , Invasividade Neoplásica , Teratocarcinoma/complicações , Neoplasias Testiculares/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...